Yapali, S. 2021. REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT. The Liver Meeting Digital Experience-AASLD , (Washington, United States Of America), 490-491.

Yapali, S., (2021). REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT . The Liver Meeting Digital Experience-AASLD (pp.490-491). Washington, United States Of America

Yapali, Suna. "REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT," The Liver Meeting Digital Experience-AASLD, Washington, United States Of America, 2021

Yapali, Suna. "REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT." The Liver Meeting Digital Experience-AASLD , Washington, United States Of America, pp.490-491, 2021

Yapali, S. (2021) . "REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT." The Liver Meeting Digital Experience-AASLD , Washington, United States Of America, pp.490-491.

@conferencepaper{conferencepaper, author={Suna YAPALI}, title={REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT}, congress name={The Liver Meeting Digital Experience-AASLD}, city={Washington}, country={United States Of America}, year={2021}, pages={490-491} }